In his quest to cure his daughter’s ultra-rare disease, Matt Wilsey might also be changing the way drugs are made, Stanford Business magazine reports.
Carolyn Bertozzi, the co-director of Stanford's interdisciplinary program ChEM-H, reflects here on the program and her goals for the future.
Fanconi anemia inspired a collaboration between Stanford scientists to develop a method for detecting problematic molecules known as aldehydes.
To explain her work, Stanford chemistry professor Carolyn Bertozzi, PhD, often turns to analogies. Cancer cells, she says, are like M&M'S with a hard sugar coating. …
A few months ago I had the opportunity to watch some undergraduate teams pitch their start up biotech ideas to a group of Stanford scientists …
I knew that many of the drugs we use today were first identified in plants. What I didn’t know was in how many cases those …
I've been writing about medical science for close to 20 years now, and in that time I shudder to think how often I’ve written …
Earlier this year I wrote about some fascinating research from the lab of chemist Justin Du Bois, PhD, who has been working with naturally occurring toxins …
Yesterday Stanford chemistry professor W.E. Moerner, PhD, was named a co-winner of the 2014 Nobel Prize in Chemistry for his work in super-resolution microscopy. In the …
Earlier today, Stanford University's W.E. Moerner, PhD, was one of three scientists to be awarded the Nobel Prize in Chemistry for work in super-resolution microscopy. …
Stanford chemistry professor W.E. Moerner, PhD, has been named a co-winner of the 2014 Nobel Prize in Chemistry. An announcement was made earlier this morning by …
“There actually are websites where people make predictions about who will get the Nobel Prize, and I’m happy to report I wasn’t on any of …
Proteins control nearly all of life's functions, but how they self-assemble or fold is an unsolved problem in biology. Understanding how folding goes awry could …
